{"url":"https://lda.senate.gov/api/v1/filings/d8aeb8f1-ee2f-49ab-a393-c8b162c17a7d/","filing_uuid":"d8aeb8f1-ee2f-49ab-a393-c8b162c17a7d","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2025,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/d8aeb8f1-ee2f-49ab-a393-c8b162c17a7d/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Leslee K. Gilbert, Vice President","dt_posted":"2026-01-20T13:44:22-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 Maine Avenue, SW","registrant_address_2":"Suite 800","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":39837,"url":"https://lda.senate.gov/api/v1/registrants/39837/","house_registrant_id":32802,"name":"VAN SCOYOC ASSOCIATES","description":"Government Relations Consultant","address_1":"800 Maine Avenue, SW","address_2":"Suite 800","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"H. STEWART VAN SCOYOC","contact_telephone":"+1 202-638-1950","dt_updated":"2026-01-30T16:27:15.999039-05:00"},"client":{"id":204464,"url":"https://lda.senate.gov/api/v1/clients/204464/","client_id":1009230,"name":"ARUP LABORATORIES, INC.","general_description":"Diagnostic testing laboratory","client_government_entity":false,"client_self_select":null,"state":"UT","state_display":"Utah","country":"US","country_display":"United States of America","ppb_state":"UT","ppb_state_display":"Utah","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Monitor the following: Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Public Law 119-21, One Big Beautiful Bill Act, generally","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33930,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"LATOURETTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65218,"prefix":null,"prefix_display":null,"first_name":"MATT","nickname":null,"middle_name":null,"last_name":"HENKEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R.3152/S.1546, Patent Eligibility Restoration Act of 2025, Laboratory technology related issues FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally H.R.5269/S.2761, Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 (RESULTS Act), Entirety Monitor the following: Possible Reconciliation, FY2026, Health related provisions Possible Health policy package Prescription drug costs, generally VALID Act, Diagnostic Lab Testing Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Public Health reporting initiatives","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33930,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"LATOURETTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65218,"prefix":null,"prefix_display":null,"first_name":"MATT","nickname":null,"middle_name":null,"last_name":"HENKEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"H.R.3152/S.1546, Patent Eligibility Restoration Act of 2025, Laboratory technology related issues FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally H.R.5269/S.2761, Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 (RESULTS Act), Entirety Monitor the following: Possible Reconciliation, FY2026, Health related provisions Possible Health policy package Prescription drug costs, generally VALID Act, Diagnostic Lab Testing Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Public Health reporting initiatives","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33930,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"LATOURETTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65218,"prefix":null,"prefix_display":null,"first_name":"MATT","nickname":null,"middle_name":null,"last_name":"HENKEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}